GD — Society for Dermopharmacy
 |
Issue 1 (2006) |
GD
News
10th Annual Meeting of the Society for Dermopharmacy in
Münster on 4th und 5th April 2006
Meeting
Presents Numerous Novelties of Interdisciplinary Significance
Participants at 10th Annual Meeting of the GD, taking place in the Westphalian
university town Münster on 4th and 5th April 2006, may look forward
to numerous novelties from all areas of dermopharmacy. The meeting will
not only inform about new findings from pharmaceutical, dermatological
and cosmetological research but also introduce different new activities
and projects of the GD. Scientific meeting heads are the director of the
dermatological university clinic and secretary general of Deutsche Dermatologische
Gesellschaft (DDG) (German Dermatological Society), Professor Dr. Thomas
Luger, as well as Professor Dr. Klaus Müller, Institut für Pharmazeutische
und Medizinische Chemie (Institute for Pharmaceutical and Medicinal Chemistry),
Münster University.
Venue of the two-day event will be Mövenpick Hotel in Münster.
Besides the diversified scientific main program taking place, as a matter
of tradition, on the second meeting day, also symposia and seminars are
presented dealing with special subjects. Moreover, a scientific poster presentation
and an evening event complement the program.
Care research
in dermatology
Already for the fourth time within a GD Annual Meeting, the GD
department Dermatotherapy will organize a symposium on the subject "Health
economy in dermatology" in the morning of the first event day. This
time the focus will be on dermatological care research by means of which
new findings on the care situation of patients suffering from dermatological
diseases are to be obtained.
For this aim a center for dermatological care research has been established
under the direction of professor Dr. Matthias Augustin at the university
dermatological clinic Hamburg which will be presented in the scope of the
symposium. From the view of care research the medicament regulation in Germany
will equally be subject of discussion. Referee on this topic is professor
Dr. Dr. Reinhard Rychlik of Institut für Empirische Gesundheitsökonomie
(Institute for Empiric Health Economy) located in Burscheid.
Professor Dr. Thomas Luger, director of Dermatological
University Clinic Münster, has taken on the scientific direction
of 10th Annual Meeting of the GD in cooperation with professor Dr.
Klaus Müller of Institut für Pharmazeutische und Medizinische
Chemie (Institute for Pharmaceutical and Medicinal Chemistry) of Münster
University.
Surveys pertain to care research accomplished by the Hamburg research group
in which also pharmacies are to be included. They are at present recruited
in the context of a new project by the GD which aims at an area-wide network
of skin-competent pharmacies all over Germany. The GD president Dr. Joachim
Kresken will inform about the current status and objectives of this new
project.
Skin aging and light
protection in focus
A symposium by the GD department Dermocosmetics taking place in the afternoon
of the first event day will deal with dermocosmetic concepts and active
agents for the retardation of skin ageing. Presented is the demographic
background of the growing anti-aging markets, molecular bases of skin aging
as well as new vehicle systems for cosmetical active agents. The currently
used active agents are subject to scientific assessment.
Further dermocosmetic subjects are addressed in the course of the scientific
main program. Here, among other subjects a relatively new method for the
evaluation of sun protection products will be presented by which a mutual
light protection factor against UVB and UVA radiation can be determined.
In a noontime seminar, new insights about skin care at itching dermatoses
are presented.
Skin-relevant research
also in pharmacies
Several lectures in the scientific main program reflect the fact
that skin-relevant research is also performed in pharmaceutical university
institutes. Thus, the scientific meeting head professor Dr. Klaus Müller
will present synthetical lapacho compounds with potential against psoriasis
whereas professor Dr. Andreas Hensel from the Institut für Pharmazeutische
Biologie, Universität Münster (Institut for Pharmaceutical Biology
at Münster University) will inform about vegetable polysaccharides
and procyanidines as derma-active agents.
Professor
Dr. Monika Schäfer-Korting of the Institut für Pharmazie, Freie
Universität Berlin (Institute for Pharmacy of Free University) will
explain by example of a topical anti-androgen in which way the effectiveness
of products for external application can be increased by means of a specific
prodrug-development. How the active agent localization in modern carrier
systems, in particular lipid-nano-dispersions, can be determined will
be revealed by Dr. Wolfgang Mehnert of the Institut für Pharmazeutische
Technologie, Freie Universität Berlin (Institute for Pharmaceutical
Technology of Free University Berlin).
| The scientific program: further information on 10th Annual Meeting of the GD can be retrieved at the internet address www.gd-online.de. |
Novelties in
dermatological therapy
10th annual meeting of the GD will also inform about numerous news in
dermatological therapy. Accordingly, Professor Dr. Harald Gollnick, president
of Deutsche Dermatologische Gesellschaft (German Dermatological Society)
will lecture about acne as chronical disease and its significance for
therapy. Equally in a noontime seminar novel clinical and pharmaco-economic
findings on the application of biologicals at psoriasis are presented.
Professor Dr. Hans Merk, director of Dermatological University Clinic,
Aix-la-Chapelle deals with a completely different complex of problems
which are only seldom considered at scientific meetings. He will give
a presentation as position paper in the scientific main program on the
subject "Pharmaco-genetical aspects of dermatics selection in practice".
Further prominent lecturers in the scientific main program are professor
Dr. Dr. Thomas Bieber and professor Dr. Thomas Schwarz, directors at Dermatological
University Clinics Bonn respectively Kiel. They will inform about the
significance of dendritical cells for the immune therapy of the atopical
eczema respectively the protective effect of Interleukin-12 from UV-induced
apoptosis.
Recent research results of Dermatological University Clinic Münster
will be introduced by professor Dr. Stefan Beissert and Professor Dr.
Dr. Martin Steinhoff. Their lecture topics are new immune modulators and
their significance in dermatology respectively proteasis-activated receptors
as targets for anti-inflammatorily effective drugs.
Professor Dr. Isaak Effendy, Dermatological Clinic Bielefeld, will comment
on a practice-oriented subject of likewise importance both for dermatologists
and pharmacists. He will present a concept for interdisciplinary management
of onychomycosis which had been recently developed by an expert group
of the GD.
News on
dermatological therapy
The schedule for the meeting had been arranged in a way that sufficient
time is left for the interdisciplinary and interprofessional exchange
of ideas - always popular at GD events. A good opportunity represents
the evening event in a typical Münster locality in the scope of which
professor Dr. Ralf Paus, Lübeck, will give a humorous lecture concerning
the subject loss of hair.
Although still German speaking, the GD annual meeting will this time possibly
implicate even more international flair. Awaited are besides participants
from Germany, Austria and Switzerland also guests from Hungary due to
the fact that the annual meeting of the German-Hungarian Dermatological
Society will take place one day after 10th annual meeting of the GD in
hotel Mövenpick in Münster.